Please wait a minute...
浙江大学学报(医学版)  2014, Vol. 43 Issue (2): 129-134    DOI: 10.3785/j.issn.1008-9292.2014.03.001
专题报道     
去铁酮与人有机阳离子转运体及有机阴离子转运体1体外相互作用研究
孔思思,涂美娟,杨希,赵垒,周慧,曾苏,蒋惠娣
浙江大学药学院药物分析与药物代谢研究室 浙江省抗肿瘤药物临床前研究重点
实验室,浙江 杭州 310058
In vitro interaction of deferiprone with cellular membrane transporters of hOCTs and hOAT1
KONG Si-si, TU Mei-juan, YANG Xi, ZHAO Lei, ZHOU Hui, ZENG Su, JIANG Hui-di
Laboratory of Pharmaceutical Analysis and Drug Metabolism, Zhejiang Provincial Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China
全文: PDF(848 KB)  
摘要: 

目的:建立细胞裂解液中去铁酮测定的液相色谱-串联质谱(LC-MS/MS)方法,体外考察去铁酮与人有机阳离子转运体(hOCTs)及有机阴离子转运体1(hOAT1)的相互作用。方法:以Agilent Eclipse Plus C18柱(2.1 mm×50 mm, 3.5 μm)为分析柱;0.1%甲酸-水(v/v)和0.1%甲酸-乙腈(v/v)为流动相,梯度洗脱;应用电喷雾离子源(ESI源)、多反应监测(MRM)模式进行检测;应用稳定表达hOCTs及hOAT1的细胞模型(MDCK-hOCTs和MDCK-hOAT1)考察去铁酮对经典底物在细胞内积聚的影响;比较去铁酮在转空载体的mock细胞及MDCK-hOCTs中积聚的差异,以及经典抑制剂对其积聚的影响。结果:去铁酮在5~300 nmol/L的浓度范围内线性关系良好;准确度大于94%,日内相对标准偏差小于2%。300 μmol/L去铁酮使hOCTs经典底物MPP+在MDCK-hOCTs的积聚降低至阴性对照的70.4%~87.1%;去铁酮在MDCK-hOCTs细胞和mock细胞中的积聚无明显差别,且经典抑制剂对去铁酮的积聚无明显抑制作用;100 μmol/L去铁酮对hOAT1经典底物6-CF在MDCK-hOAT1细胞中的积聚无显著影响。结论:本实验建立的方法适用于细胞裂解液中去铁酮的定量分析;去铁酮对hOCT1和hOCT3有一定的抑制作用,对hOCT2和hOAT1则无明显抑制作用;hOCTs在去铁酮跨膜转运中不起主导作用。

关键词 酮类铁螯合剂质谱分析法色谱法 液相有机阳离子转运子有机阴离子转运子1    
Abstract

Objective: To develop a LC-MS/MS method for determination of deferiprone in cell lysate and to study the potential interaction between deferiprone and hOCTs or hOAT1 transporters in vitro. Methods: The determination was performed on an Agilent Eclipse Plus C18 column(3.5 μm, 2.1 mm×50 mm).The gradient mobile phase was composed of solvent A: 0.1% formic acid in water, and B: 0.1% formic acid in acetonitrile. The mass spectrometer with an electrospray interface was operated in positive ion mode with multiple reaction monitoring (MRM) scan mode monitored the ion pair of deferiprone at m/z 140→96, or phenacetin at m/z 180→110. The effects of deferiprone on the accumulation of typical substrates of hOCTs and hOAT1 were evaluated by MDCK-hOCTs and MDCK-hOAT1 cells respectively. The accumulation of deferiprone was also investigated in MDCK-hOCTs cells and mock cells with or without typical inhibitors.Results: The standard curve was linear over the range of 5-300 nmol/L. The assay recovery of deferiprone was above 94%, and the intra-day precision (RSD) was less than 2.0%. The accumulation of MPP+ in MDCK-hOCTs cells with 300 μmol/L deferiprone were 73.5%, 87.1% and 70.4%, respectively. The uptake of deferiprone in MDCK-hOCTs and mock cells did not show significant difference. Deferiprone of 100 μmol/L did not significantly affect the accumulation of 6-CF in MDCK-hOAT1 cell. Conclusion: The method is sensitivity and suitable for the determination of deferiprone in cell lysate. Deferiprone can significantly inhibit hOCT1 and hOCT3, but has no effects on hOCT2 and hOAT1. hOCTs may not play a major role in the transport of deferiprone.

Key wordsKetones    Iron chelating agents    Mass spectrometry    Chromatography, liquid    Organic cation transporters    Organic anion transporter 1
收稿日期: 2013-10-11     
基金资助:

国家科技重大专项(2012ZX09506001-004)

通讯作者: 蒋惠娣(1965-),女,博士,教授,博士生导师,主要从事药物分析与药物代谢研究;E-mail: hdjiang@zju.edu.cn   
Corresponding author: JIANG Hui-di, E-mail: hdjiang@zju.edu.cn   
作者简介: 孔思思(1990-),女,硕士研究生,主要从事药物分析与药物代谢研究;E-mail: kss223355@163.com
服务  
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章  
孔思思
涂美娟
杨希
赵垒
周慧
曾苏
蒋惠娣

引用本文:

孔思思,涂美娟,杨希,赵垒,周慧,曾苏,蒋惠娣. 去铁酮与人有机阳离子转运体及有机阴离子转运体1体外相互作用研究[J]. 浙江大学学报(医学版), 2014, 43(2): 129-134.
KONG Si-si, TU Mei-juan, YANG Xi, ZHAO Lei, ZHOU Hui, ZENG Su, JIANG Hui-di. In vitro interaction of deferiprone with cellular membrane transporters of hOCTs and hOAT1. Journal of ZheJiang University(Medical Science), 2014, 43(2): 129-134.

链接本文:

http://www.zjujournals.com/xueshu/med/CN/10.3785/j.issn.1008-9292.2014.03.001      或      http://www.zjujournals.com/xueshu/med/CN/Y2014/V43/I2/129

[1] 马婷婷,王毅,陈晓倩,赵筱萍. 液相色谱-质谱联用导向的黄葵胶囊肾保护活性物质研究[J]. 浙江大学学报(医学版), 2017, 46(1): 66-73.
[2] 高玉海 等. 淫羊藿总黄酮胶囊对生长期大鼠骨密度和骨形态计量学的影响[J]. 浙江大学学报(医学版), 2016, 45(6): 581-586.
[3] 邱丽萍, 孙文均. 应用高效液相色谱串联质谱法检测细胞内神经酰胺的含量[J]. 浙江大学学报(医学版), 2015, 44(4): 429-434.
[4] 陶珊, 梁欣莹, 王怡, 王毅. 通脉养心丸中心肌保护活性物质的筛选[J]. 浙江大学学报(医学版), 2015, 44(2): 145-153.
[5] 缪成贵, 周国梁, 秦梅颂, 陈建中, 李成凤, 张兵. 禹州漏芦总黄酮对类风湿关节炎大鼠治疗机制研究[J]. 浙江大学学报(医学版), 2015, 44(1): 43-48.
[6] 申潜,余露山,周慧,曾苏. 应用反相高效液相色谱法同时测定积雪草提取物中羟基积雪草苷、积雪草苷及其苷元[J]. 浙江大学学报(医学版), 2014, 43(2): 135-140.
[7] 章向群,吴凌华,陈方军,张伊,陈璐. 高效液相色谱-质谱法测定伏格列波糖片中伏格列波糖含量[J]. 浙江大学学报(医学版), 2014, 43(2): 141-144.
[8] 姚青青,屈伯宣,周权,曾苏. 非索非那定对映体柱前手性衍生化反相高效液相色谱分析方法的建立[J]. 浙江大学学报(医学版), 2014, 43(2): 155-159.
[9] 柴晓鹃,胡海红,余露山,曾苏. 人谷胱甘肽硫转移酶的克隆表达及活性鉴定[J]. 浙江大学学报(医学版), 2014, 43(2): 168-174.
[10] 朱倩颖, 余露山, 郑国刚, 谢升谷, 陶巧凤. 盐酸伐昔洛韦的手性分离及其对映体杂质的含量测定[J]. 浙江大学学报(医学版), 2014, 43(2): 164-167.
[11] 朱倩颖,余露山,郑国刚,谢升谷,陶巧凤. 马来酸噻吗洛尔原料和滴眼剂中对映体杂质的含量测定[J]. 浙江大学学报(医学版), 2014, 43(2): 160-163.
[12] 叶淑雅,李向荣,邵盈盈. 紫心甘薯总黄酮对CCl4诱导的小鼠急性肝损伤的保护作用[J]. 浙江大学学报(医学版), 2013, 42(6): 649-653+684.
[13] 崔大练, 马玉心. 大吴风草总黄酮含量季节动态变化及对逆境胁迫的响应[J]. 浙江大学学报(医学版), 2013, 42(3): 319-325.
[14] . 生物样品中组胺含量测定方法的研究进展[J]. 浙江大学学报(医学版), 2012, 41(6): 681-688.
[15] . 重性抑郁障碍患者血浆天冬氨酸和甘氨酸及天冬酰胺水平的变化[J]. 浙江大学学报(医学版), 2012, 41(2): 132-138.